Stay updated on EXN407 Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.

Latest updates to the EXN407 Safety & Tolerability Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated to include new results and detailed descriptions of the study involving EXN407, including specific objectives and methodologies for evaluating ocular safety and pharmacokinetics in subjects with Diabetic Macular Oedema (DMO). Notably, the results reporting dates have also been added.SummaryDifference22%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Diabetic Macular Edema, while retaining the names of collaborators and the revision number.SummaryDifference27%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to EXN407 Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EXN407 Safety & Tolerability Clinical Trial page.